AYTU
Aytu BioPharma, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.21
−3.28%Forward multiples
Based on analyst estimates
- P/E forward
- 8.84x
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 2.10x
- P/S forward
- 0.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.67x
- Price / sales
- 0.42x
- Price / cash flow
- 14.14x
Enterprise value
- Enterprise value
- $19.9M
- EV / sales
- 0.35x
- EV / EBITDA
- -0.73x
- EV / EBIT
- -1.32x
- Market cap
- $23.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026